Immunomodulation in cancer therapeutics

By Ehrke M.J.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1105-1119

Elsevier

Access to resources Recommend Favorite

Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application

By Garaci E.   Pica F.   Rasi G.   Favalli C.  

International Journal of Immunopharmacology, Vol. 22, Iss. 12, 2000-12 ,pp. : 1067-1076

Elsevier

Access to resources Recommend Favorite

RAS inhibitors: potential for cancer therapeutics

By Kloog Y.   Cox A.D.  

Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. : 398-402

Elsevier

Access to resources Recommend Favorite

Histone modification: the 'next wave' in cancer therapeutics

By Chung D.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 10-11

Elsevier

Access to resources Recommend Favorite

Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemoprevention - Basic Science, Research and Treatment

By DiGiovanna J.J.  

Transplantation Proceedings, Vol. 30, Iss. 6, 1998-09 ,pp. : 2771-2775

Elsevier

Access to resources Recommend Favorite